Valuation: PHARMAGEST INTER.

Market Cap 51Cr 60Cr 48Cr 44Cr 83Cr 5.7TCr 84Cr 566.22Cr 221.88Cr 2.86TCr 223.9Cr 219.06Cr 9.5TCr P/E 2026 *
11.3x
P/E 2027 * 10.4x
Enterprise Value 42Cr 48Cr 39Cr 35Cr 67Cr 4.6TCr 68Cr 456.68Cr 178.96Cr 2.3TCr 180.59Cr 176.68Cr 7.66TCr EV / Sales 2026 *
1.64x
EV / Sales 2027 * 1.44x
Free-Float
31.97%
Yield 2026 *
4.21%
Yield 2027 * 4.39%
Manager TitleAgeSince
Chief Executive Officer 57 22/04/2022
Director of Finance/CFO - 01/01/2023
Chief Tech/Sci/R&D Officer - 01/07/2018
Director TitleAgeSince
Chairman 61 25/06/2026
Director/Board Member 58 16/06/2011
Director/Board Member 57 01/01/2013
Change 5-day change 1-year change 3-year change Capi.($)
-2.75%-3.30%-4.57%+62.46% 22TCr
+1.50%-0.21%+68.48%+127.30% 11TCr
-3.24%-3.71%-31.11%-43.84% 11TCr
-2.02%-5.69%-23.46%-33.11% 8.93TCr
-2.22%-5.33%-30.23%-0.76% 5.98TCr
-2.51%-3.00%-21.26%-19.64% 4.95TCr
-7.39%-1.56%+4.50%+227.81% 4.31TCr
-4.61%-0.30%+4.69%+106.71% 4.19TCr
-2.57%-2.33%-11.06%+12.56% 3.85TCr
Average -2.85%+0.21%-4.89%+48.83% 8.5TCr
Weighted average by Cap. -2.38%-0.49%-2.04%+44.89%

Financials

2026 *2027 *
Net sales 25Cr 29Cr 24Cr 22Cr 41Cr 2.81TCr 41Cr 278.74Cr 109.23Cr 1.41TCr 110.22Cr 107.84Cr 4.68TCr 27Cr 31Cr 25Cr 23Cr 43Cr 2.99TCr 44Cr 296.83Cr 116.32Cr 1.5TCr 117.38Cr 114.83Cr 4.98TCr
Net income 4.35Cr 5.04Cr 4.08Cr 3.72Cr 6.99Cr 481.78Cr 7.09Cr 48Cr 19Cr 241.37Cr 19Cr 19Cr 802.9Cr 4.91Cr 5.69Cr 4.61Cr 4.2Cr 7.89Cr 543.8Cr 8Cr 54Cr 21Cr 272.44Cr 21Cr 21Cr 906.27Cr
Net Debt -9.96Cr -12Cr -9.34Cr -8.51Cr -16Cr -1.1TCr -16Cr -109.54Cr -43Cr -552.65Cr -43Cr -42Cr -1.84TCr -13Cr -15Cr -12Cr -11Cr -20Cr -1.4TCr -21Cr -139.12Cr -55Cr -701.91Cr -55Cr -54Cr -2.33TCr
Logo PHARMAGEST INTER.
Equasens is No. 1 in France for publishing and integrating software programs for pharmacies, hospitals, healthcare facilities, laboratories, retirement homes and healthcare professionals. Net sales break down by activity as follows: - pharmacy software publishing and integration (72.8%): software programs for managing data bases, information, inventories, orders, electronic care records, etc.; - publishing of IT solutions for health and medical/social establishments (15.9%): publishing and integration of software packages for retirement homes, hospitals and care homes (software for managing admissions, billing, receipt and accounting management, care management, supply management, etc.); - development of solutions and infrastructures for e-Health (6.2%): digital communication, telemedicine and telehealth solutions; - software publishing for private practitioners and medical assistants (4.2%); - development of financing solutions for leased goods (0.9%; Nanceo). Net sales are distributed geographically as follows: France (87.5%), Italy (6.1%), Belgium (3%), Germany (2.5%), the United Kingdom (0.8%), and Ireland (0.1%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-